FDA Moves to Fast-Track Gene Editing Safety Standards
WASHINGTON, D.C. — Federal regulators are advancing new safety standards for gene-editing therapies, aiming to speed development of treatments for rare and previously incurable diseases while tightening oversight of potential …
FDA Moves to Fast-Track Gene Editing Safety Standards Read More